scispace - formally typeset
C

Chelsea Ayers

Researcher at Veterans Health Administration

Publications -  23
Citations -  941

Chelsea Ayers is an academic researcher from Veterans Health Administration. The author has contributed to research in topics: Systematic review & Medicine. The author has an hindex of 8, co-authored 18 publications receiving 281 citations. Previous affiliations of Chelsea Ayers include Oregon Health & Science University.

Papers
More filters
Journal ArticleDOI

Racial and Ethnic Disparities in COVID-19-Related Infections, Hospitalizations, and Deaths : A Systematic Review.

TL;DR: A systematic review evaluating racial/ethnic disparities in SARS-CoV-2 infection rates and COVID-19 outcomes, factors contributing to disparities, and interventions to reduce them suggests that impacts of CO VID-19 differ among U.S. racial/ ethnic groups.
Journal ArticleDOI

Pharmacotherapy for methamphetamine/amphetamine use disorder-a systematic review and meta-analysis

TL;DR: On the basis of low to moderate strength evidence, most medications evaluated for methamphetamine/amphetamine use disorder have not shown a statistically significant benefit, however, there is low strength evidence that methylphenidate may reduce use.
Journal ArticleDOI

Pharmacotherapy for Cocaine Use Disorder—a Systematic Review and Meta-analysis

TL;DR: Most of the pharmacotherapies studied were not effective for treating cocaine use disorder, but bupropion, psychostimulants, and topiramate may improve abstinence, and antipsychotics may improve retention.
Journal ArticleDOI

A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders

TL;DR: Co-occurring stimulant/opioid use disorder is an important problem for targeting future research, and medication trials for methamphetamine use disorder are lacking in this population.
Journal ArticleDOI

Pharmacotherapy for the Treatment of Cannabis Use Disorder: A Systematic Review.

TL;DR: Evidence exists that several drug classes, including cannabinoids and SSRIs, are ineffective in treating CUD, and an urgent need exists for more research to identify effective pharmacologic treatments.